Internet Archive Scholar

Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Prostatic Neoplasms, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 14, Status: Authorised

2019 Case Medical Research  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (86.7 kB)
https://web.archive.org/web/20200508110640/https://www.ema.europa.eu/en/documents/overview/xtandi-epar-medicine-overview_en.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact
doi:10.31525/cmr-9a26f7 fatcat:vrkcw3ov6fcabhreuxmcprg75u
Citation

"Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Prostatic Neoplasms, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 14, Status: Authorised." Case Medical Research (2019)